Home/Filings/4/0001628280-24-024782
4//SEC Filing

Josephs Paul 4

Accession 0001628280-24-024782

CIK 0001005286other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 5:48 PM ET

Size

8.7 KB

Accession

0001628280-24-024782

Insider Transaction Report

Form 4
Period: 2024-05-20
Josephs Paul
DirectorChief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    2024-05-208,975516,025 total
  • Award

    Common Stock

    2024-05-20+525,000525,000 total
  • Award

    Performance-Based Restricted Stock Units

    2024-05-20+1,500,0000 total
    Exp: 2029-05-20Common Stock (1,500,000 underlying)
Footnotes (4)
  • [F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
  • [F2]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.
  • [F4]The performance-based restricted stock units vest, if it all, based on the Issuer's achievement of certain stock prices.

Issuer

LIFECORE BIOMEDICAL, INC. \DE\

CIK 0001005286

Entity typeother

Related Parties

1
  • filerCIK 0002022547

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:48 PM ET
Size
8.7 KB